404 results about "Hyperpiesis" patented technology

The present invention provides methods for treating hypertension and conditions associated with hypertension utilizing compounds that selectively inhibit PI-3-K p110δ activity.

The invention relates to a method and device for dialysis and or bulk fluid removal by generating a fibrosis chamber within a body cavity and performing dialysis or bulk fluid removal. An implantable medical device is described having a fibrosis chamber and a pump. A dialysis chamber and an optional electrodialysis unit can further be provided. An additional controller uses sensory feedback to regulate the fluid levels by altering the extracellular fluid retention within the fibrosis chamber. This device can be used for the treatment of patients with chronic kidney disease who may also be suffering from cardiorenal syndrome and hypertension.

Vitamin K is effective in counteracting cardiovascular disorders such as the reduction in arterial elasticity normally associated with the aging process. A pharmaceutical composition or nutritional formulation comprising vitamin K can be used to combat age-related stiffening of the arteries, and the consequences thereof, namely pulmonary congestion, hypertension, left ventricular hypertrophy, congestive (right sided) heart failure, left sided or left ventricular failure, chronic cardiac failure, angina pectoris, myocardial infarction, Mönckeberg's sclerosis and stroke. In various embodiments, vitamin K can also be used to reduce or reverse calcification of a blood vessel in pre-existing cardiovascular disorders such as arteriosclerosis.

The invention relates to a health-care tea and relative technique, which uses hemp seed and sweet tea as basic materials, assisted with other natural Chinese medicine drug, to be used on various diseases. The inventive health-care tea combines the characters of food, health-care product and drug, with good taste, and treatment on hypertension, hyperlipemia, high cholesterol and constipation, without side effect.

Preferred embodiments of the present invention are related to novel therapeutic drug combinations and methods for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome. More particularly, aspects of the present invention are related to using a combination of cicletanine and a second antihypertensive agent (preferably a calcium antagonist, an ACE inhibitor, or an angiotensin II receptor antagonist) for treating and/or preventing hypertension and complications in patients with diabetes and/or metabolic syndrome.

The invention provides a composition, a drug, a food additive and a food, which comprises ground lotus and/or a lotus extract and a lactic acid bacterium. The composition, drug, food additive and food of the invention can be used to relieve and treat constipation, excessive sensitivity to cold, hemorrhoid, ear ringing, menopausal syndrome, hypertension and menstrual disorder.

The invention the invention relates to a capsule for treating hyperpiesis and apoplexy and a preparation method thereof. The capsule comprises the active ingredients made of the raw materials based on parts by weight: 6-12 parts of scorpion, 4-8 parts of centipede, 9-20 parts of the larva of silkworm with botrytis, 4-10 parts of leech, 6-12 parts of earthworm, 15-40 parts of turtleback, 20-30 parts of radix puerariae, 30-90 parts of radix astragali, 9-12 parts of peach kernel, 9-12 parts of safflower, 9-12 parts of angelica, 9-12 parts of szechuan lovage rhizome, 9-15 parts of red paeonia, 9-15 parts of notoginseng, 9-20 parts of salvia miltiorrhiza, 20-40 parts of prepared rhizome of rehmannia, 9-15 parts of rhizoma gastrodiae and 15-30 parts of uncaria. The raw materials are sliced, dried, crushed, extracted, concentrated, dried, processed by ball milling and filled in the capsule. The capsule can be used for treating hyperpiesis, apoplexy and coronary heart disease, and the preparation method is simple and easy to implement.

An application of an invented medicinal composition in preparing the medicines for treating primary hypertension and protecting heart and kidney is disclosed.

The invention relates to methods and compositions for identifying subjects having, or predisposed to having, gestational diabetes, preeclampsia, and gestational hypertension. The methods are applicable to urine and/or blood samples and can be conducted prior to the third trimester of pregnancy.

The invention relates to a traditional Chinese medicine for treating hyperpiesis and a preparation method, the medicine can effectively treat hyperpiesis and has double efficacy of herbal cuisine and diet therapy in treating hyperpiesis. The invention comprises the following bulk drugs: 10-45 of propolis powder, 9-40 of natto powder, 9-40 of wild jujube seed, 9-40 of gastrodia tuber, 8-30 of corn stigma, 8-30 of cassia seed, 8-25 of pagodatree flower powder, 8-25 of kudzuvine root, 5-15 of gambir plant, 5-15 of scutellaria laterifolia, 5-15 of haw, 2-10 of apocynum, 2-10 of earthworm, 2-10 of evodia fruit, 8-25 of selfheal, 5-15 of Chinese gentian root, 5-15 of antelope horn, 5-15 of bupleurum, 5-15 of red-rooted salvia, 2-10 of radish seed and 2-10 of Chinese magnoliavine, wherein the unit of weight is parts by weight.

The present invention relates to a Chinese medicine capsule preparation for effectively curing hypertension and coronary heart disease. Said capsule preparation is made up by using 14 Chinese medicinal materials of gastrodia root, uncaria stem and thorn, chrysanthemum flower, tortoise plastron, lyceum berry and others and adding nifedipine through a certain preparation process.

Compositions and methods are disclosed for decreasing the amount and activity of matrix-degrading metalloproteinases (MMPs) in and around cells. The compositions and methods are useful for treating and/or preventing symptoms of diseases including but not limited to Hypertension, Type II Diabetes, and Metabolic Syndrome X. Such treatment is effected by normalizing the blood plasma's protease activity, reducing blood pressure, preventing membrane receptor cleavage, and reducing the levels of insulin resistance and oxygen free radicals in the blood stream.

The present invention relates to the prognosis and risk assessment in pregnant women to develop pregnancy-induced hypertension and/or preeclampsia by the determination of marker levels.

The invention discloses the ingredients and the preparation method of an oral pulse pellet pharmaceutical preparation of metoprolol salts. The pharmaceutical preparation is a multi-layered coated pellet which has a basic structure of an immediate-release pellet core, an alkaline layer and a retardation layer containing remedium cardinale of 20 to 100 mg from inside to outside, wherein, the retardation layer contains polyacrylic resin 3, the weight increment of which is 100 to 240 percent of the immediate-release pellet core; the alkaline layer is a medicinal inorganic alkaline adjuvant, the weight of which is 10 to 30 percent of the immediate-release pellet core. After being taken, the pulse pellet begins to release immediately till a complete release is obtained after a time lag of 3 to 4 hours and achieves the effect of one pulse release. The oral pulse pellet pharmaceutical preparation can effectively prevent angina pectoris, hyperpiesis and other diseases from being triggered due to the rise of blood pressure and heart rate within a few hours after a patient awakens and wakes up in the early morning.

The present invention relates to thiazolidinedione analogues that are useful for treating hypertension.

The invention discloses a traditional Chinese medicine for treating hypertension. The medicine is composed of the following components, by weight: 10-12 parts of the dried rhizome of rehmannia, 1-3 parts of herba epimedii, 10-12 parts of Coptis chinensis, 10-12 parts of fossil fragments, 10-12 parts of coked hawthorn, 3-5 parts of American ginseng, 10-12 parts of wolfberry fruit, 10-12 parts of mulberry, 10-12 parts of Roughhaired Holly Root, 8-10 parts of loofah sponge, 8-10 parts of radix sileris, 8-10 parts of uncaria, 10-12 parts of Uncinata Spikemoss Herb, 8-10 parts of gastrodia elata, 5-8 parts of underleaf pearl, 10-12 parts of raw oyster, 8-10 parts of Fructus Rosae Laevigatae, and 10-12 parts of mulberry leaves. The traditional Chinese medicine for treating hypertension has effects of tonifying qi, nourishing kidney and liver, dredging collaterals and promoting blood circulation, and advantages of good and quick curative effect on hypertension, and no toxic or side effect.

The invention discloses an automatic identification method for physiological indexes of urinalysis test paper. The method is characterized by comprising the following steps: (1) acquiring an urinalysis test paper image uploaded by a user; (2) carrying out image enhancement processing on the obtained urinalysis test paper; (3) carrying out adaptive threshold segmentation on the enhanced picture toobtain each to-be-tested item: indicating the position of each color block on the urinalysis test paper; (4) different mobile phone camera parameters are different; (5) training a BP neural network for each test item, and inputting the color blocks subjected to color difference correction in the step (4) into the corresponding BP neural networks to obtain categories corresponding to the color blocks; and (6) comparing the standard colorimetric cards according to the categories corresponding to the color blocks to obtain corresponding physiological indexes. The identification method is simple and accurate. The problems of illumination interference and low human eye colorimetric accuracy are avoided, and the identification method can be used for early diagnosis and follow-up visit of chronicdiseases such as chronic nephrotic patients, diabetic patients and hypertension patients and early screening of healthy people.

The invention discloses a Chinese medicinal composition for treating hypertension, and relates to the technical field of Chinese medicaments. The composition is prepared from 8 gouts of purely natural Chinese medicinal materials such as Chinese prickly ash, cassia seed, raw hawthorn, Chinese angelica, self-heal, Chinese wolfberry, snakegourd fruit and coptis in a specified ratio. The Chinese medicinal composition for treating the hypertension has the advantages of high healing rate, relapse prevention, no toxic or side effect, low cost, simplicity in preparation process and the like.

The present invention relates to a Chinese medicine for curing high blood pressure and myocardial diseases, which is prepared with 10 portions of ginseng, 20 portions of astragalus root, 10 portions of cassia twig, 10 portions of cassia barkcassia bark, 5 portions of red sage root, 15 portions of safflower, 10 portions of radix polygoni multiflori preparata, 10 portions of Chinese wolfberry, 10 portions of malaytea scurfpea fruit , 10 portions of oriental waterplantain rhizome, 10 portions of fourstamen stephania root, 10 portions of eucommia bark, 10 portions of Chinese magnoliavine fruit, 10 portions of doubleteeth pubescent angelica root, 15 portions of suberect spatholobus stem, 15 portions of Chinese taxillus twig, 10 portions of szechuan lovage rhizome, 10 portions of turmeric root-tuber, 10 portions of notoginseng, 10 portions of costus root, 10 portions of figwort root and 5 portions of liquoric root. The Chinese medicine mainly treats myocardial diseases such as coronary heart disease, angina pectoris and high blood pressure.